| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
134,025 |
109,419 |
$15.86M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
54,300 |
50,771 |
$8.30M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
38,233 |
36,266 |
$5.79M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
32,667 |
30,917 |
$4.55M |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
1,579 |
1,494 |
$4.27M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,381 |
15,342 |
$2.73M |
| G0378 |
Hospital observation service, per hour |
2,335 |
2,264 |
$2.39M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,954 |
7,976 |
$2.23M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,776 |
6,205 |
$1.88M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
34,733 |
32,978 |
$1.86M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,623 |
16,993 |
$1.82M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,611 |
14,008 |
$1.69M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
261 |
243 |
$1.44M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,706 |
1,694 |
$1.37M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,010 |
7,810 |
$1.36M |
| 90834 |
Psychotherapy, 45 minutes with patient |
7,789 |
3,259 |
$1.33M |
| 93458 |
|
661 |
649 |
$1.33M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20,867 |
15,927 |
$1.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,856 |
6,753 |
$1.21M |
| J7170 |
Injection, emicizumab-kxwh, 0.5 mg |
14 |
13 |
$1.19M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,696 |
3,620 |
$1.15M |
| 80053 |
Comprehensive metabolic panel |
100,371 |
75,869 |
$986K |
| 93975 |
|
2,524 |
2,446 |
$910K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,450 |
2,407 |
$871K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,127 |
4,915 |
$808K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,333 |
16,204 |
$785K |
| 90832 |
Psychotherapy, 30 minutes with patient |
4,930 |
2,591 |
$679K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,605 |
4,201 |
$583K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,634 |
3,454 |
$570K |
| 96367 |
|
2,634 |
1,976 |
$560K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,932 |
4,779 |
$546K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
24,361 |
21,260 |
$504K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
803 |
797 |
$477K |
| 47562 |
|
199 |
197 |
$461K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,450 |
2,428 |
$456K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,908 |
4,902 |
$452K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,394 |
2,379 |
$445K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
24,669 |
23,503 |
$435K |
| 93970 |
|
1,441 |
1,421 |
$405K |
| 86900 |
|
16,672 |
13,723 |
$354K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
453 |
449 |
$331K |
| 93976 |
|
1,235 |
1,198 |
$329K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27,670 |
24,202 |
$312K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
707 |
703 |
$310K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,958 |
188 |
$305K |
| 12001 |
|
923 |
922 |
$300K |
| G0008 |
Administration of influenza virus vaccine |
7,704 |
7,686 |
$294K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,995 |
2,273 |
$272K |
| 96402 |
|
967 |
697 |
$262K |
| 36415 |
Collection of venous blood by venipuncture |
83,834 |
61,524 |
$261K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
38,627 |
36,379 |
$257K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,003 |
2,587 |
$245K |
| 90836 |
|
2,254 |
1,014 |
$243K |
| 80061 |
Lipid panel |
22,985 |
21,577 |
$234K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,537 |
1,522 |
$218K |
| 12011 |
|
633 |
631 |
$211K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
70 |
52 |
$210K |
| 36000 |
|
10,825 |
10,538 |
$206K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
297 |
227 |
$203K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,704 |
3,612 |
$197K |
| 96415 |
|
3,724 |
3,119 |
$190K |
| 96401 |
|
836 |
343 |
$179K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,401 |
1,399 |
$169K |
| 97162 |
|
1,755 |
1,741 |
$168K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,308 |
1,280 |
$163K |
| 99215 |
Prolong outpt/office vis |
1,511 |
1,439 |
$162K |
| 76641 |
|
1,905 |
1,751 |
$155K |
| 86901 |
|
14,584 |
11,959 |
$150K |
| 70496 |
|
871 |
863 |
$150K |
| 36430 |
|
722 |
538 |
$148K |
| 86850 |
|
16,522 |
13,859 |
$145K |
| 87631 |
|
3,566 |
3,512 |
$141K |
| 76770 |
|
937 |
935 |
$138K |
| 87428 |
|
5,930 |
5,790 |
$135K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,039 |
11,512 |
$133K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,947 |
4,774 |
$133K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,456 |
1,342 |
$126K |
| 71046 |
Radiologic examination, chest; 2 views |
16,090 |
15,681 |
$125K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,796 |
4,791 |
$124K |
| 83880 |
|
8,648 |
7,904 |
$124K |
| 53450 |
|
98 |
98 |
$120K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,574 |
636 |
$114K |
| 75574 |
|
669 |
663 |
$110K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
970 |
796 |
$110K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
22,453 |
22,057 |
$100K |
| 90686 |
|
8,801 |
8,786 |
$98K |
| 88307 |
|
883 |
792 |
$96K |
| 88342 |
|
2,329 |
2,028 |
$95K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,682 |
1,649 |
$95K |
| 93971 |
|
1,640 |
1,568 |
$94K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
894 |
888 |
$92K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,497 |
10,268 |
$90K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,589 |
1,426 |
$90K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,525 |
12,908 |
$89K |
| 76937 |
|
580 |
566 |
$86K |
| 93017 |
|
2,261 |
2,232 |
$86K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,946 |
7,757 |
$85K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
95,710 |
78,659 |
$84K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
115 |
113 |
$82K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,434 |
1,266 |
$79K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,118 |
1,417 |
$79K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
432 |
429 |
$77K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,931 |
10,486 |
$77K |
| 88304 |
|
2,929 |
2,668 |
$75K |
| 90670 |
|
2,196 |
2,191 |
$74K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,188 |
3,142 |
$73K |
| 86780 |
|
7,459 |
7,380 |
$72K |
| 81025 |
|
34,947 |
31,832 |
$70K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,650 |
1,471 |
$70K |
| 76830 |
Ultrasound, transvaginal |
2,103 |
2,071 |
$70K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
261 |
184 |
$69K |
| 90677 |
|
634 |
628 |
$68K |
| 0002A |
|
1,816 |
1,810 |
$67K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,290 |
1,108 |
$66K |
| 86480 |
|
3,646 |
3,598 |
$64K |
| 10060 |
|
262 |
256 |
$63K |
| 87536 |
|
2,097 |
2,005 |
$63K |
| G0009 |
Administration of pneumococcal vaccine |
1,831 |
1,818 |
$63K |
| 90671 |
|
216 |
216 |
$62K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
225 |
194 |
$62K |
| 0001A |
|
1,754 |
1,747 |
$61K |
| 76801 |
|
610 |
577 |
$60K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,813 |
917 |
$59K |
| 88184 |
|
627 |
581 |
$59K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
373 |
366 |
$53K |
| 70486 |
|
943 |
935 |
$50K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
380 |
267 |
$50K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,986 |
1,772 |
$49K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,491 |
6,341 |
$49K |
| 77066 |
Tomosynthesis, mammo |
441 |
438 |
$49K |
| 87799 |
|
2,027 |
1,513 |
$49K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
380 |
363 |
$48K |
| 91200 |
|
1,011 |
997 |
$46K |
| 97165 |
|
508 |
506 |
$46K |
| 76536 |
|
732 |
721 |
$46K |
| 70491 |
|
370 |
368 |
$45K |
| 80197 |
|
5,550 |
3,393 |
$44K |
| 76642 |
|
639 |
624 |
$44K |
| J2785 |
Injection, regadenoson, 0.1 mg |
911 |
896 |
$42K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,561 |
1,542 |
$42K |
| C1889 |
Implantable/insertable device, not otherwise classified |
1,419 |
1,398 |
$42K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,234 |
3,586 |
$42K |
| 80050 |
General health panel |
2,292 |
2,129 |
$41K |
| 85610 |
|
25,132 |
22,180 |
$41K |
| 86769 |
|
1,497 |
1,461 |
$41K |
| 38222 |
|
26 |
26 |
$41K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,115 |
493 |
$40K |
| 82728 |
|
11,847 |
11,039 |
$40K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
11,011 |
10,876 |
$40K |
| 87497 |
|
2,299 |
1,538 |
$39K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
2,147 |
2,138 |
$39K |
| 90715 |
|
3,646 |
3,587 |
$38K |
| 96368 |
|
493 |
385 |
$38K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
311 |
308 |
$38K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,036 |
1,009 |
$38K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
193 |
170 |
$37K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
93 |
91 |
$36K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
18 |
12 |
$36K |
| 71250 |
|
372 |
370 |
$35K |
| 80076 |
|
5,888 |
5,551 |
$35K |
| 59025 |
Fetal non-stress test |
207 |
160 |
$35K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
28 |
25 |
$34K |
| 86923 |
|
1,504 |
890 |
$34K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
356 |
352 |
$34K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
37,891 |
33,658 |
$34K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,779 |
12,381 |
$33K |
| 99443 |
|
654 |
623 |
$32K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,001 |
945 |
$31K |
| 88185 |
|
740 |
611 |
$31K |
| 82105 |
|
4,054 |
3,507 |
$30K |
| G0010 |
Administration of hepatitis b vaccine |
774 |
764 |
$29K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
21 |
15 |
$28K |
| 99442 |
|
652 |
631 |
$28K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
243 |
241 |
$28K |
| 87522 |
Neg quan hep c or qual rna |
1,976 |
1,833 |
$27K |
| 83735 |
|
18,150 |
13,361 |
$26K |
| 77065 |
Tomosynthesis, mammo |
303 |
285 |
$26K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
252 |
252 |
$25K |
| 87517 |
|
1,539 |
1,340 |
$25K |
| 83970 |
|
1,468 |
1,387 |
$25K |
| J0897 |
Injection, denosumab, 1 mg |
14 |
13 |
$24K |
| 86803 |
|
9,982 |
9,857 |
$23K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,597 |
1,050 |
$23K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,148 |
1,113 |
$23K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,266 |
1,241 |
$23K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
490 |
467 |
$23K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
58 |
52 |
$23K |
| 82977 |
|
14,167 |
10,941 |
$23K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,096 |
2,075 |
$22K |
| 82784 |
|
7,599 |
3,858 |
$22K |
| 85027 |
|
15,677 |
14,452 |
$21K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
79 |
79 |
$21K |
| 88341 |
|
742 |
673 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
622 |
609 |
$20K |
| 86706 |
|
7,471 |
7,071 |
$20K |
| 82607 |
|
5,438 |
5,234 |
$19K |
| C1760 |
Closure device, vascular (implantable/insertable) |
547 |
531 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
155 |
154 |
$19K |
| 73562 |
|
1,783 |
1,696 |
$19K |
| 90732 |
|
306 |
305 |
$18K |
| 87507 |
|
185 |
183 |
$18K |
| 72100 |
|
1,192 |
1,183 |
$18K |
| 72131 |
|
241 |
240 |
$18K |
| 84439 |
|
6,953 |
6,598 |
$18K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
188 |
187 |
$18K |
| 96376 |
|
3,294 |
2,844 |
$17K |
| 83540 |
|
11,378 |
10,726 |
$17K |
| 73030 |
|
2,112 |
1,989 |
$17K |
| 87340 |
|
8,643 |
8,476 |
$16K |
| 83550 |
|
10,075 |
9,522 |
$16K |
| J1453 |
Injection, fosaprepitant, 1 mg |
440 |
290 |
$16K |
| 0003A |
|
397 |
397 |
$16K |
| 46260 |
|
12 |
12 |
$16K |
| 82248 |
|
16,708 |
13,432 |
$15K |
| 94060 |
|
61 |
61 |
$15K |
| 97116 |
|
528 |
310 |
$15K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
87 |
36 |
$14K |
| 91320 |
|
192 |
190 |
$14K |
| 84100 |
|
12,190 |
9,096 |
$14K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
26 |
25 |
$13K |
| 86704 |
|
4,540 |
4,436 |
$13K |
| 73630 |
|
2,901 |
2,795 |
$13K |
| 73560 |
|
1,848 |
1,763 |
$12K |
| 99205 |
Prolong outpt/office vis |
84 |
84 |
$12K |
| 96417 |
|
1,596 |
1,010 |
$12K |
| 90674 |
|
912 |
912 |
$12K |
| 0224U |
|
331 |
329 |
$12K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,132 |
1,109 |
$12K |
| 99441 |
|
267 |
260 |
$12K |
| 82043 |
|
5,959 |
5,831 |
$11K |
| 83615 |
|
12,957 |
9,233 |
$11K |
| 95249 |
|
207 |
205 |
$11K |
| 94375 |
|
325 |
310 |
$11K |
| 0124A |
|
276 |
276 |
$11K |
| 74174 |
|
102 |
102 |
$11K |
| 83655 |
|
1,875 |
1,868 |
$11K |
| 82378 |
|
2,425 |
2,072 |
$10K |
| 82570 |
|
7,213 |
6,258 |
$10K |
| 0004A |
|
242 |
242 |
$10K |
| C1769 |
Guide wire |
2,371 |
2,211 |
$10K |
| 73610 |
|
2,381 |
2,262 |
$10K |
| 99385 |
|
91 |
90 |
$10K |
| 88112 |
|
301 |
292 |
$10K |
| 83883 |
|
4,498 |
1,881 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
4,836 |
4,668 |
$10K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,749 |
1,736 |
$10K |
| 90694 |
|
450 |
440 |
$10K |
| 84153 |
|
1,578 |
1,484 |
$10K |
| 73502 |
|
1,037 |
998 |
$10K |
| 70498 |
|
434 |
429 |
$10K |
| 86592 |
|
2,854 |
2,818 |
$9K |
| 82803 |
|
1,228 |
1,074 |
$9K |
| 85730 |
|
18,350 |
16,930 |
$9K |
| 86334 |
|
1,780 |
1,367 |
$9K |
| 90746 |
|
266 |
259 |
$8K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
46 |
46 |
$8K |
| 84403 |
|
1,491 |
1,428 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
87 |
87 |
$8K |
| 73130 |
|
2,470 |
2,387 |
$8K |
| 93320 |
|
377 |
368 |
$8K |
| 29540 |
|
41 |
41 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,216 |
1,041 |
$7K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
277 |
275 |
$7K |
| 86708 |
|
1,364 |
1,351 |
$7K |
| 81003 |
|
22,718 |
21,212 |
$7K |
| 97802 |
|
867 |
860 |
$7K |
| 86665 |
|
453 |
395 |
$7K |
| J3490 |
Unclassified drugs |
2,726 |
2,524 |
$7K |
| 86301 |
|
1,055 |
920 |
$7K |
| 84702 |
|
7,928 |
6,957 |
$7K |
| 92551 |
|
186 |
186 |
$6K |
| 84466 |
|
1,236 |
1,189 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
33 |
24 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,518 |
11,013 |
$6K |
| 96127 |
|
601 |
601 |
$6K |
| 86870 |
|
50 |
39 |
$6K |
| 83520 |
|
2,050 |
1,906 |
$6K |
| 87901 |
|
45 |
44 |
$6K |
| 90480 |
|
157 |
155 |
$6K |
| 84484 |
|
22,563 |
18,329 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,710 |
7,526 |
$6K |
| 99173 |
|
163 |
163 |
$6K |
| 88142 |
|
309 |
305 |
$6K |
| 84165 |
|
2,886 |
2,311 |
$6K |
| 83690 |
|
19,300 |
17,871 |
$6K |
| 0042T |
|
116 |
115 |
$6K |
| 86787 |
|
1,766 |
1,683 |
$6K |
| 97010 |
|
546 |
206 |
$6K |
| 80051 |
|
760 |
703 |
$5K |
| 86361 |
|
1,426 |
1,395 |
$5K |
| 11721 |
|
343 |
343 |
$5K |
| 87899 |
|
455 |
409 |
$5K |
| C1780 |
Lens, intraocular (new technology) |
176 |
12 |
$5K |
| 97161 |
|
51 |
51 |
$5K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
18 |
16 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
46 |
45 |
$5K |
| 73110 |
|
1,492 |
1,381 |
$5K |
| 84550 |
|
7,998 |
5,001 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
96 |
59 |
$5K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
426 |
416 |
$5K |
| 82670 |
|
1,047 |
1,031 |
$5K |
| 83001 |
|
1,185 |
1,173 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
10,054 |
9,492 |
$5K |
| 86762 |
|
1,447 |
1,436 |
$4K |
| 12002 |
|
12 |
12 |
$4K |
| 76870 |
|
379 |
373 |
$4K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
12 |
12 |
$4K |
| 99051 |
|
576 |
563 |
$4K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,844 |
1,405 |
$4K |
| 82746 |
|
1,341 |
1,295 |
$4K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
216 |
216 |
$4K |
| 82150 |
|
3,308 |
2,593 |
$4K |
| 93242 |
|
88 |
86 |
$4K |
| 82533 |
|
1,264 |
1,030 |
$4K |
| 84146 |
|
763 |
744 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
824 |
812 |
$4K |
| 90656 |
|
542 |
542 |
$4K |
| 86765 |
|
1,470 |
1,460 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,491 |
2,918 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,302 |
15,019 |
$4K |
| 51702 |
|
15 |
14 |
$4K |
| 76857 |
|
124 |
123 |
$4K |
| 99386 |
|
36 |
36 |
$4K |
| 87480 |
|
1,269 |
1,251 |
$4K |
| 93308 |
|
13 |
13 |
$4K |
| 81001 |
|
14,332 |
13,663 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
27 |
26 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,978 |
4,354 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
7,477 |
7,124 |
$3K |
| 83002 |
|
1,009 |
1,002 |
$3K |
| 86644 |
|
437 |
425 |
$3K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
211 |
76 |
$3K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
481 |
467 |
$3K |
| 73700 |
|
26 |
24 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
42 |
42 |
$3K |
| 86593 |
|
926 |
886 |
$3K |
| 82947 |
|
2,167 |
1,923 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,137 |
1,398 |
$3K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,201 |
1,166 |
$3K |
| 74455 |
|
13 |
13 |
$3K |
| 86039 |
|
1,316 |
1,097 |
$3K |
| 84156 |
|
3,388 |
2,889 |
$3K |
| 73564 |
|
170 |
162 |
$3K |
| C1874 |
Stent, coated/covered, with delivery system |
24 |
24 |
$3K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
185 |
177 |
$3K |
| 86141 |
|
1,615 |
1,464 |
$3K |
| 90744 |
|
343 |
343 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,594 |
2,406 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,992 |
2,713 |
$3K |
| 87510 |
|
1,033 |
1,018 |
$3K |
| 90739 |
|
53 |
53 |
$3K |
| 97014 |
|
162 |
72 |
$3K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
226 |
178 |
$3K |
| 86300 |
|
422 |
375 |
$3K |
| 86255 |
|
552 |
533 |
$3K |
| 82232 |
|
742 |
651 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,991 |
7,010 |
$3K |
| 82950 |
|
572 |
524 |
$2K |
| 72141 |
|
13 |
13 |
$2K |
| 85045 |
|
4,582 |
3,624 |
$2K |
| 73080 |
|
666 |
626 |
$2K |
| 88313 |
|
881 |
691 |
$2K |
| 86376 |
|
704 |
699 |
$2K |
| 97803 |
|
229 |
216 |
$2K |
| 80069 |
|
2,451 |
1,657 |
$2K |
| 84270 |
|
626 |
616 |
$2K |
| 83021 |
|
1,587 |
1,453 |
$2K |
| 74018 |
|
304 |
298 |
$2K |
| 36591 |
|
109 |
90 |
$2K |
| 82550 |
|
3,859 |
3,665 |
$2K |
| 88237 |
|
25 |
24 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,575 |
9,793 |
$2K |
| 86695 |
|
262 |
260 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,449 |
1,420 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,157 |
3,318 |
$2K |
| 82565 |
|
3,346 |
2,979 |
$2K |
| 93325 |
|
391 |
381 |
$2K |
| 90662 |
|
84 |
83 |
$2K |
| 74150 |
|
41 |
41 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
29 |
12 |
$2K |
| 87590 |
|
833 |
819 |
$2K |
| 0072A |
|
64 |
64 |
$2K |
| 81002 |
|
16,592 |
13,703 |
$2K |
| 92250 |
|
211 |
202 |
$2K |
| 85651 |
|
7,226 |
6,902 |
$2K |
| 36600 |
|
96 |
88 |
$2K |
| 76775 |
|
27 |
27 |
$2K |
| 84480 |
|
676 |
654 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
939 |
726 |
$2K |
| 0064A |
|
37 |
37 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,518 |
1,437 |
$2K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
24 |
24 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,285 |
4,786 |
$2K |
| 86140 |
|
6,965 |
6,654 |
$2K |
| 82465 |
|
460 |
351 |
$2K |
| 82962 |
|
12,704 |
9,433 |
$2K |
| 72170 |
|
197 |
196 |
$2K |
| 92083 |
|
221 |
212 |
$2K |
| 86735 |
|
466 |
461 |
$2K |
| 0071A |
|
76 |
76 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
205 |
181 |
$1K |
| 73590 |
|
861 |
824 |
$1K |
| 88311 |
|
379 |
357 |
$1K |
| 92557 |
|
26 |
26 |
$1K |
| 83010 |
|
662 |
540 |
$1K |
| 86705 |
|
261 |
259 |
$1K |
| 87186 |
|
2,614 |
2,397 |
$1K |
| 86360 |
|
171 |
156 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,279 |
3,118 |
$1K |
| 77080 |
|
38 |
38 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,499 |
12,277 |
$1K |
| 84460 |
|
4,294 |
3,368 |
$1K |
| 93799 |
|
137 |
98 |
$1K |
| 0054A |
|
28 |
28 |
$1K |
| 87040 |
|
4,198 |
2,939 |
$1K |
| 84402 |
|
285 |
284 |
$1K |
| 85378 |
|
4,806 |
4,650 |
$1K |
| 90680 |
|
487 |
485 |
$1K |
| 90461 |
|
1,980 |
1,967 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,000 |
2,979 |
$1K |
| C1781 |
Mesh (implantable) |
24 |
24 |
$1K |
| 96411 |
|
101 |
63 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,211 |
2,171 |
$1K |
| 73090 |
|
695 |
660 |
$1K |
| S0028 |
Injection, famotidine, 20 mg |
3,388 |
3,134 |
$1K |
| 82247 |
|
3,729 |
2,770 |
$1K |
| 90474 |
|
382 |
380 |
$945.14 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,078 |
2,058 |
$916.39 |
| 80055 |
|
118 |
85 |
$908.61 |
| 93225 |
|
12 |
12 |
$903.79 |
| 87077 |
|
1,888 |
1,547 |
$862.05 |
| 85384 |
|
1,085 |
925 |
$811.73 |
| 84075 |
|
3,375 |
2,481 |
$808.31 |
| 94726 |
|
13 |
12 |
$788.41 |
| 84450 |
|
2,800 |
1,945 |
$786.40 |
| J2501 |
Injection, paricalcitol, 1 mcg |
221 |
24 |
$775.99 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
752 |
581 |
$774.90 |
| 87070 |
|
2,913 |
2,811 |
$769.71 |
| 82627 |
|
123 |
122 |
$753.63 |
| 86431 |
|
552 |
548 |
$744.72 |
| 86800 |
|
215 |
202 |
$736.69 |
| 87640 |
|
62 |
62 |
$699.33 |
| 85240 |
|
103 |
93 |
$677.86 |
| 90661 |
|
43 |
43 |
$661.96 |
| 83605 |
|
4,200 |
3,586 |
$657.76 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,739 |
2,030 |
$643.94 |
| 80320 |
|
1,551 |
1,429 |
$618.62 |
| 85044 |
|
752 |
666 |
$607.05 |
| 86147 |
|
35 |
27 |
$583.18 |
| 0154A |
|
13 |
13 |
$582.79 |
| 82103 |
|
117 |
115 |
$535.09 |
| 84132 |
|
2,317 |
1,928 |
$521.87 |
| 0012A |
|
13 |
13 |
$480.00 |
| J1815 |
Injection, insulin, per 5 units |
766 |
567 |
$460.75 |
| 86355 |
|
69 |
67 |
$446.71 |
| 82310 |
|
875 |
843 |
$442.43 |
| 86200 |
|
97 |
97 |
$402.10 |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
13 |
12 |
$395.79 |
| 72040 |
|
13 |
13 |
$391.90 |
| 93356 |
|
322 |
320 |
$385.93 |
| 85018 |
|
1,374 |
1,314 |
$384.98 |
| 87338 |
|
44 |
44 |
$383.02 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
405 |
390 |
$376.55 |
| 82040 |
|
1,620 |
1,517 |
$360.29 |
| 76813 |
|
13 |
13 |
$346.23 |
| 84305 |
|
81 |
80 |
$342.31 |
| 83695 |
|
66 |
65 |
$337.21 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
204 |
172 |
$335.18 |
| 87205 |
|
1,520 |
1,097 |
$334.12 |
| 87660 |
|
447 |
439 |
$334.10 |
| 90647 |
|
85 |
85 |
$332.06 |
| 86357 |
|
70 |
68 |
$321.06 |
| 71100 |
|
213 |
211 |
$318.82 |
| 86160 |
|
335 |
168 |
$317.50 |
| 86003 |
|
334 |
177 |
$311.67 |
| 88300 |
|
76 |
71 |
$306.08 |
| 99152 |
|
1,311 |
1,275 |
$295.10 |
| 90633 |
|
188 |
187 |
$290.91 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
13 |
$290.11 |
| 84520 |
|
2,666 |
2,316 |
$288.39 |
| 82553 |
|
1,447 |
1,137 |
$286.99 |
| J1630 |
Injection, haloperidol, up to 5 mg |
682 |
604 |
$284.49 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,087 |
1,837 |
$271.82 |
| 99153 |
Mod sedat endo service >5yrs |
1,159 |
1,128 |
$269.56 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,274 |
1,165 |
$265.72 |
| 86359 |
|
60 |
56 |
$260.23 |
| 80081 |
|
12 |
12 |
$245.30 |
| 84481 |
|
146 |
127 |
$240.50 |
| 83921 |
|
44 |
44 |
$238.64 |
| 88275 |
|
14 |
12 |
$230.36 |
| 86235 |
|
166 |
94 |
$228.45 |
| 84295 |
|
1,560 |
1,425 |
$228.08 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
13 |
13 |
$227.27 |
| 88312 |
|
12 |
12 |
$220.78 |
| 84155 |
|
1,221 |
1,175 |
$216.56 |
| 88271 |
|
15 |
12 |
$212.06 |
| 82435 |
|
1,470 |
1,356 |
$209.76 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
218 |
190 |
$207.98 |
| 73140 |
|
122 |
119 |
$202.36 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,205 |
1,820 |
$197.66 |
| 80329 |
|
262 |
235 |
$197.17 |
| 85306 |
|
29 |
24 |
$193.12 |
| 83498 |
|
13 |
13 |
$187.47 |
| 80074 |
|
20 |
19 |
$183.71 |
| 80321 |
|
526 |
354 |
$181.23 |
| 83519 |
|
67 |
64 |
$177.36 |
| 92134 |
|
252 |
241 |
$171.17 |
| 90723 |
|
92 |
92 |
$169.82 |
| 82374 |
|
777 |
720 |
$169.80 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
376 |
211 |
$168.64 |
| 85597 |
|
16 |
15 |
$157.91 |
| 84166 |
|
40 |
38 |
$155.70 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
552 |
547 |
$141.89 |
| 86304 |
|
17 |
15 |
$138.13 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,318 |
2,835 |
$134.92 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,512 |
1,490 |
$133.14 |
| 87088 |
|
394 |
390 |
$131.85 |
| 73070 |
|
45 |
44 |
$130.83 |
| J2060 |
Injection, lorazepam, 2 mg |
464 |
409 |
$129.64 |
| 82542 |
|
54 |
54 |
$127.32 |
| 82397 |
|
60 |
55 |
$119.35 |
| 83090 |
|
12 |
12 |
$118.09 |
| 82610 |
|
12 |
12 |
$116.69 |
| 82107 |
|
12 |
12 |
$115.94 |
| 90707 |
|
69 |
67 |
$114.15 |
| 90651 |
|
47 |
47 |
$105.66 |
| 82390 |
|
26 |
26 |
$104.80 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,199 |
1,184 |
$103.53 |
| 82668 |
|
12 |
12 |
$103.38 |
| 84145 |
|
122 |
113 |
$98.37 |
| 82375 |
|
1,602 |
1,384 |
$98.24 |
| 87081 |
|
372 |
370 |
$98.22 |
| 81015 |
|
1,135 |
900 |
$95.41 |
| 86317 |
|
12 |
12 |
$94.43 |
| 85613 |
|
25 |
25 |
$93.08 |
| 86701 |
|
14 |
14 |
$90.97 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,192 |
2,581 |
$88.36 |
| 85670 |
|
53 |
52 |
$87.65 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
36 |
24 |
$87.56 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
50 |
39 |
$86.14 |
| 84425 |
|
25 |
24 |
$83.52 |
| 87449 |
|
38 |
37 |
$79.46 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
1,299 |
1,151 |
$74.88 |
| 90734 |
|
48 |
48 |
$65.15 |
| 85303 |
|
13 |
12 |
$63.68 |
| 92060 |
|
14 |
14 |
$63.67 |
| 90700 |
|
81 |
81 |
$62.66 |
| 82985 |
|
12 |
12 |
$60.32 |
| 73552 |
|
67 |
66 |
$58.52 |
| 86707 |
|
12 |
12 |
$52.05 |
| 87350 |
|
12 |
12 |
$51.90 |
| 86696 |
|
12 |
12 |
$49.34 |
| 83050 |
|
1,626 |
1,384 |
$49.23 |
| 84478 |
|
12 |
12 |
$47.37 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
325 |
321 |
$46.56 |
| J3480 |
Injection, potassium chloride, per 2 meq |
43 |
26 |
$37.20 |
| 90685 |
|
14 |
14 |
$36.78 |
| J1836 |
Injection, metronidazole, 10 mg |
100 |
85 |
$35.50 |
| 91300 |
|
3,040 |
2,584 |
$35.49 |
| J3411 |
Injection, thiamine hcl, 100 mg |
39 |
37 |
$34.21 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
31 |
28 |
$34.15 |
| 86225 |
|
37 |
37 |
$29.99 |
| 73060 |
|
99 |
94 |
$27.98 |
| 86709 |
|
12 |
12 |
$27.62 |
| 82785 |
|
52 |
52 |
$27.31 |
| 82330 |
|
285 |
252 |
$24.62 |
| 90648 |
|
136 |
135 |
$24.27 |
| 85347 |
|
443 |
357 |
$23.96 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
497 |
411 |
$22.27 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
16 |
12 |
$21.72 |
| 89051 |
|
334 |
211 |
$20.77 |
| C9113 |
Injection, pantoprazole sodium, per vial |
38 |
27 |
$18.49 |
| S0030 |
Injection, metronidazole, 500 mg |
218 |
167 |
$17.27 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
13 |
$16.78 |
| 85014 |
|
386 |
346 |
$16.71 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
22 |
18 |
$16.56 |
| 86336 |
|
12 |
12 |
$15.59 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
63 |
62 |
$14.88 |
| A0425 |
Ground mileage, per statute mile |
12 |
12 |
$14.03 |
| 80145 |
|
24 |
24 |
$10.61 |
| 87210 |
|
422 |
410 |
$10.48 |
| 87102 |
|
14 |
13 |
$7.57 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
25 |
25 |
$6.65 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
524 |
517 |
$4.02 |
| 87220 |
|
14 |
13 |
$3.84 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
417 |
394 |
$3.70 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
438 |
415 |
$3.01 |
| 91312 |
|
309 |
309 |
$2.80 |
| J1940 |
Injection, furosemide, up to 20 mg |
23 |
16 |
$2.23 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
56 |
54 |
$1.41 |
| 91307 |
|
188 |
172 |
$1.20 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
151 |
147 |
$0.98 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
58 |
58 |
$0.70 |
| 91305 |
|
59 |
58 |
$0.59 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
62 |
60 |
$0.44 |
| 91306 |
|
37 |
37 |
$0.37 |
| G9905 |
Patient not screened for tobacco use |
29 |
29 |
$0.23 |
| 91315 |
|
18 |
18 |
$0.18 |
| 91308 |
|
12 |
12 |
$0.12 |
| 91301 |
|
13 |
13 |
$0.12 |
| 3051F |
|
17 |
15 |
$0.09 |
| 1036F |
|
1,563 |
1,474 |
$0.03 |
| 1123F |
|
46 |
40 |
$0.02 |
| G8484 |
Influenza immunization was not administered, reason not given |
226 |
225 |
$0.01 |
| 4004F |
|
504 |
484 |
$0.01 |
| 90710 |
|
55 |
55 |
$0.00 |
| 99080 |
|
661 |
180 |
$0.00 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
12 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
51 |
49 |
$0.00 |
| 94729 |
|
171 |
171 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
44 |
43 |
$0.00 |
| 3046F |
|
40 |
38 |
$0.00 |
| 92133 |
|
39 |
38 |
$0.00 |
| 86038 |
|
16 |
12 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
155 |
155 |
$0.00 |
| 93226 |
|
13 |
12 |
$0.00 |
| C1729 |
Catheter, drainage |
15 |
15 |
$0.00 |
| 90473 |
|
12 |
12 |
$0.00 |
| 87653 |
|
14 |
14 |
$0.00 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
44 |
43 |
$0.00 |
| 90698 |
|
384 |
382 |
$0.00 |
| 90696 |
|
54 |
54 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
240 |
240 |
$0.00 |
| 92567 |
|
25 |
25 |
$0.00 |
| 95012 |
|
53 |
52 |
$0.00 |
| 51600 |
|
13 |
13 |
$0.00 |
| 88720 |
|
60 |
40 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
16 |
13 |
$0.00 |
| 73600 |
|
14 |
14 |
$0.00 |
| 82270 |
|
13 |
13 |
$0.00 |
| 3044F |
|
19 |
18 |
$0.00 |